Service de pharmacologie clinique

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


630 publications

... | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | ...
2016
 
Cannabis and its effects on driving skills.
Bondallaz P., Favrat B., Chtioui H., Fornari E., Maeder P., Giroud C., 2016/11. Forensic science international, 268 pp. 92-102. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7667A10BF648]
 
The emerging role of multiplex tandem mass spectrometry analysis for therapeutic drug monitoring and personalized medicine
Decosterd L.A., Widmer N., André P., Aouri M., Buclin T., 2016/11. TrAC Trends in Analytical Chemistry, 84 pp. 5-13. Peer-reviewed.
[DOI][serval:BIB_61127FFB9A94]
Sélection de cas issus des centres régionaux de pharmacovigilance
Weiler Stefan, Taegtmeyer Anne B., Müller Sabine, Rollason Victoria, Livio Françoise, Ceschi Alessandro, Kullak-Ublick Gerd A., 2016/09/14. Forum Médical Suisse pp. 757-763.
[URN][DOI][serval:BIB_9DCD175710D5]
 
Cascaded PID controller for anaesthesia delivery.
Simalatsar A., Guidi M., Buclin T., 2016/08. Conference proceedings, 2016 pp. 533-536. Peer-reviewed.
[DOI][Pmid][serval:BIB_2E02DD33E302]
 
Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.
Fuchs A., Rotzinger A., Cavassini M., Bugnon O., Buclin T., Schneider M.P., Csajka C., 2016/08. Therapeutic drug monitoring, 38 (4) pp. 506-515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C5EDAE96F2A]
Privacy-preserving genomic testing in the clinic: a model using HIV treatment.
McLaren P.J., Raisaro J.L., Aouri M., Rotger M., Ayday E., Bartha I., Delgado M.B., Vallet Y., Günthard H.F., Cavassini M. et al., 2016/08. Genetics in medicine, 18 (8) pp. 814-822. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C52D051D158A]
 
Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications
Marzolini C., Gibbons S., Khoo S., Back D., 2016/07. J Antimicrob Chemother, 71 (7) pp. 1755-8. Peer-reviewed.
[DOI][Pmid][serval:BIB_DC583F272754]
Pheochromocytoma Masked by Mutation in the TH Gene.
Abid K., Afshar K., Fontana E., Ducry J., Rotman S., Stauffer E., Fellmann F., Tschopp O., Bhuiyan Z.A., Grouzmann E., 2016/07. Clinical chemistry, 62 (7) pp. 924-928. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_475789A533F9]
 
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
Barceló C., Gaspar F., Aouri M., Panchaud A., Rotger M., Guidi M., Cavassini M., Buclin T., Decosterd L.A., Csajka C. et al., 2016/07. The Journal of antimicrobial chemotherapy, 71 (7) pp. 1933-1942. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_001364580150]
 
Pregnancy outcome following maternal exposure to pregabalin may call for concern.
Winterfeld U., Merlob P., Baud D., Rousson V., Panchaud A., Rothuizen L.E., Bernard N., Vial T., Yates L.M., Pistelli A. et al., 2016/06/14. Neurology, 86 (24) pp. 2251-2257. Peer-reviewed.
[DOI][Pmid][serval:BIB_BAB64140AB78]
 
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.
Scherrer A.U., von Wyl V., Yang W.L., Kouyos R.D., Böni J., Yerly S., Klimkait T., Aubert V., Cavassini M., Battegay M. et al., 2016/05/15. Clinical infectious diseases, 62 (10) pp. 1310-1317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3E6EC9A4633]
 
Busulfan therapeutic drug monitoring for children at Geneva University Hospital
Choong E., Uppugunduri C. R., Marino D., Kuntzinger M., Doffey Lazeyras F., Lo Piccolo R., Chalandon Y., Peters C., Daali Y., Ansari M., 2016/05. dans Journée recherche clinique, HUG.
[serval:BIB_E2647D682281]
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
[Pmid][serval:BIB_61D54069EC5E]
 
Cas clinique n°5 - fibrillation auriculaire.
Guignard B., Beney Johnny, Panchaud Alice, Csajka Chantal, Meyer Philippe, 2016. pharmaJournal 07 pp. 5-9.
[serval:BIB_7A85BB8F0F8F]
 
Clinical and biochemical responses after Gamma Knife surgery for a dopamine-secreting paraganglioma: case report.
Tuleasca C., Jaquet Y., Schweizer V., Negretti L., Magaddino V., Maeder P., Abid K.A., Lhermitte B., Grouzmann E., Levivier M., 2016. Hormones (Athens, Greece), 15 (1) pp. 106-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD14D991325E]
 
Dispelling the "nice or naughty myth" with ecological fallacy.
Hoarau G., Panchaud A., Spodenkiewicz M., Baud D., Gérardin P., 2016. BMJ online p. 1.
[serval:BIB_67B43AAECC92]
Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.
Fuchs A., Zimmermann L., Bickle Graz M., Cherpillod J., Tolsa J.F., Buclin T., Giannoni E., 2016. PloS one, 11 (7) pp. e0158806. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8AEAB3EBFFC4]
 
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.
Aouri M., Barcelo C., Ternon B., Cavassini M., Anagnostopoulos A., Yerly S., Hugues H., Vernazza P., Günthard H.F., Buclin T. et al., 2016. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 44 (1) pp. 151-161.
[DOI][WoS][Pmid][serval:BIB_4B30049F72DE]
 
Multigenerational effects of the anticancer drug tamoxifen and its metabolite 4-hydroxy-tamoxifen on Daphnia pulex.
Borgatta M., Waridel P., Decosterd L.A., Buclin T., Chèvre N., 2016. Science of the Total Environment, 545-546 pp. 21-29.
[DOI][WoS][Pmid][serval:BIB_C86930422DAC]
 
Paracétamol et ibuprofène en pédiatrie : Revue critique des indications, risques et autres points controversés
Dao Kim, Laubscher Bernard, Buclin Thierry, 2016. Paediatrica, 27 (2) pp. 30-34. Peer-reviewed.
[serval:BIB_54085D8FDF37]
 
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C., 2016. Respiration; international review of thoracic diseases, 91 (4) pp. 333-348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8F67FDB86FD]
Savoir investiguer en pensant aux causes rares
Rossier Valériane, Renard Delphine, 2016. Swiss Medical Forum 16 pp. 620-622. Peer-reviewed.
[URN][serval:BIB_753FCDED1BF4]
 
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.
Vionnet J., Saouli A.C., Pascual M., Stucker F., Decosterd L.A., Moradpour D., Chtioui H., 2016. Journal of Hepatology, 65 (5) pp. 1063-1065. Peer-reviewed.
[DOI][Pmid][serval:BIB_D327874A3973]
2015
 
Pharmacokinetic modelling of dialytic clearance in a case of acyclovir intoxication.
Kissling S., Fuchs A., Gobin N., Vogt B., Burnier M., Decosterd L.A., Buclin T., Livio F., 2015/11. International Journal of Antimicrobial Agents, 45 (3) pp. 325-327. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96AB126BAC33]
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
[URN][DOI][serval:BIB_848AD57B1B48]
 
Suivi thérapeutique pharmacologique des inhibiteurs de protéines kinases
Buclin Thierry, Csajka Chantal, Guiducci Carlotta, Decosterd Laurent A, 2015/09. Innovations & Thérapeutiques en Oncologie, 1 (1) pp. 12-23.
[URN][DOI][serval:BIB_36B4E1B0267A]
 
Therapeutic drug monitoring of targeted anticancer therapy.
Decosterd L.A., Widmer N., Zaman K., Cardoso E., Buclin T., Csajka C., 2015/09. Biomarkers In Medicine, 9 (9) pp. 887-893. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E88575DAD1C]
 
Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature.
Mani L.Y., Kissling S., Viceic D., Vogt B., Burnier M., Buclin T., Renard D., 2015/07. Hemodialysis International. International Symposium On Home Hemodialysis, 19 (2) pp. 333-343. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95626566C721]
 
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.
Guidi M., Foletti G., McLaren P., Cavassini M., Rauch A., Tarr P.E., Lamy O., Panchaud A., Telenti A., Csajka C. et al., 2015/07. Antiviral Therapy, 20 (3) pp. 261-269. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60B0877DA09D]
 
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients with psychotropic treatments
Quteineh L., Vandenberghe F., Saigi Morgui N., Delacretaz A., Choong E., Gholam-Rezaee M., Magistretti P., Bondolfi G., von Gunten A., Preisig M. et al., 2015/06. dans 12th World Congress of Biological Psychiatry, Athens, Greece, June 14-18, 2015.
[serval:BIB_3618F8958220]
 
Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in subjects from the general population with present or past atypical depression
Choong E., Delacretaz A., Preisig M., Vandenberghe F., Saigi Morgui N., Quteineh L., Gholam-Rezaee M., Kutalik Z., Castelao P., Aubry J.-M. et al., 2015/06. dans 12th World congress of Biological Psychiatry (WFSBP)- 14 – 18 june 2015 - Athens, Greece.
[serval:BIB_1BAEC4811834]
 
Multiplex Mass Spectrometry Analysis of Latest-Generation Antiepileptic Drugs: A Clinically Useful Laboratory Tool for Improved Real-Time Patients' Care.
Decosterd LA, Mercier T, André P, Bertholet S, Rothuizen LE, Rossetti AO, Buclin T, 2015/06. Epileptologie, 32 (2) pp. 85-89.
[serval:BIB_070F59406BE8]
 
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E. et al., 2015/06. Journal of Clinical Psychopharmacology, 35 (3) pp. 250-259. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C8D9F29667C]
Atrophie de Lichtenberg post-vaccinale
Rochat Laurence, Gaide Olivier, Rothuizen Laura E., Genton Blaise, 2015/04/14. Forum Médical Suisse ‒ Swiss Medical Forum, 15 (16) pp. 350-352.
[URN][DOI][serval:BIB_C56D1C8F1B06]
 
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma
Kurz M., Stoeckle M., Krasniqi F., Battegay M., Marzolini C., 2015/03. Int J STD AIDS, 26 (3) pp. 212-4. Peer-reviewed.
[DOI][Pmid][serval:BIB_83F16B0032D8]
 
Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies
Moss D. M., Marzolini C., Rajoli R. K., Siccardi M., 2015. Expert Opin Drug Metab Toxicol, 11 (8) pp. 1203-17. Peer-reviewed.
[DOI][Pmid][serval:BIB_456E26B8BF12]
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
Saigi-Morgui N., Vandenberghe F., Delacrétaz A., Quteineh L., Choong E., Gholamrezaee M., Magistretti P., Aubry J.M., von Gunten A., Preisig M. et al., 2015. Journal of Clinical Psychopharmacology, 35 (5) pp. 544-552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65A415095D9E]
 
Cas clinique n°4 - prescription inappropriée chez le patient âgé: entre trop et trop peu de médicaments.
Csajka Chantal, Panchaud Alice, Guignard Bertrand, Beney Johnny, Spinewine Anne, 2015. pharmaJournal 7 pp. 5-7.
[serval:BIB_D551A62AEEBB]
Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E., Tschopp O., Triponez F., Matter M., Bilz S., Brändle M., Drechser T., Sigrist S., Zulewski H., Henzen C. et al., 2015. Plos One, 10 (5) pp. e0125426. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_26B1C674A53D]
 
Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literature.
Petit-Jean E., Buclin T., Guidi M., Quoix E., Gourieux B., Decosterd L.A., Gairard-Dory A.C., Ubeaud-Séquier G., Widmer N., 2015. Therapeutic Drug Monitoring, 37 (1) pp. 2-21. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E06AAEC7E81]
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
Vandenberghe F., Guidi M., Choong E., von Gunten A., Conus P., Csajka C., Eap C.B., 2015. Clinical Pharmacokinetics, 54 (12) pp. 1259-1272. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_594496D78157]
 
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults
Marzolini C., Sabin C., Raffi F., Siccardi M., Mussini C., Launay O., Burger D., Roca B., Fehr J., Bonora S. et al., 2015. AIDS, 29 (2) pp. 193-200. Peer-reviewed.
[DOI][Pmid][serval:BIB_7EACCBC2761B]
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
Quteineh L., Vandenberghe F., Saigi Morgui N., Delacrétaz A., Choong E., Gholam-Rezaee M., Magistretti P., Bondolfi G., Von Gunten A., Preisig M. et al., 2015. Pharmacogenetics and Genomics, 25 (5) pp. 246-258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_361B0D4F6D36]
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
Vandenberghe F., Gholam-Rezaee M., Saigí-Morgui N., Delacrétaz A., Choong E., Solida-Tozzi A., Kolly S., Thonney J., Gallo S.F., Hedjal A. et al., 2015. Journal of Clinical Psychiatry, 76 (11) pp. e1417-e1423. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DE3D0341247]
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.
Delacrétaz A., Preisig M., Vandenberghe F., Saigi Morgui N., Quteineh L., Choong E., Gholam-Rezaee M., Kutalik Z., Magistretti P., Aubry J.M. et al., 2015. Plos One, 10 (10) pp. e0139155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_200412067B84]
 
Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Schmid Y., Rickli A., Schaffner A., Duthaler U., Grouzmann E., Hysek C.M., Liechti M.E., 2015. Journal of Pharmacology and Experimental Therapeutics, 353 (1) pp. 102-111.
[DOI][Pmid][serval:BIB_03CE9B0DBFDE]
 
Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance.
Cappi G., Spiga F.M., Moncada Y., Ferretti A., Beyeler M., Bianchessi M., Decosterd L., Buclin T., Guiducci C., 2015. Analytical Chemistry, 87 (10) pp. 5278-5285.
[DOI][WoS][Pmid][serval:BIB_BFF299B734CB]
 
Médicaments, grossesse et lactation.
Delaloye J.F., Panchaud A., Weisskopf E., Winterfeld U., Rothuizen L., Vial Y., Csajka C., Buclin T., Hohlfeld P., 2015/01., 4e éd. 252 p, Médecine et Hygiène.
[serval:BIB_267D2934EC39]
 
Pharmacokinetics in hepatic impairment: Mind the protein binding.
Chtioui H., Buclin T., 2015. Journal of Hepatology, 63 (6) pp. 1539-1540. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57D522F33942]
 
Pharmacovigilance [Pharmacovigilance update].
Fogarasi Szabo N., Diezi L., Delenclos L., Renard D., Chtioui H., Rothuizen L.E., Buclin T., Livio F., 2015/01. Revue Médicale Suisse, 11 (456-457) pp. 124-128.
[URN][Pmid][serval:BIB_D8A2874AB9AF]
 
Population pharmacokinetic study to evaluate dosing strategies of imipenem in neonates and infants
Fuchs A., Giannoni E., Guidi M., Decosterd L.A., Marchetti O., Pfister M., Widmer N., Buclin T., Csajka C., 2015. pp. Abstr. 3505 dans 24th Population Approach Group in Europe (PAGE) Meeting, PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
[serval:BIB_08604FD033C0]
 
Population pharmacokinetic study to evaluate dosing strategies of imipenem in neonates and infants
Fuchs A., Giannoni E., Guidi M., Decosterd L.A., Marchetti O., Pfister M., Widmer N., Buclin T., Csajka C., 2015. dans Nano-Tera Annual Plenary Meeting.
[serval:BIB_D01690AA9CCD]
 
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
Weber-Schoendorfer C., Oppermann M., Wacker E., Bernard N., network of French pharmacovigilance centres, Beghin D., Beghin D., Cuppers-Maarschalkerweerd B., Richardson J.L., Rothuizen L.E. et al., 2015. British Journal of Clinical Pharmacology, 80 (4) pp. 727-739. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_836106A36BE1]
 
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.
Schaerer V., Haubitz S., Kovari H., Ledergerber B., Ambrosioni J., Cavassini M., Stoeckle M., Schmid P., Decosterd L., Aouri M. et al., 2015. HIV Medicine, 16 (10) pp. 599-607. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5192227BD51]
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
Vionnet J., Pascual M., Chtioui H., Giostra E., Majno P.E., Decosterd L.A., Moradpour D., 2015. BMC Gastroenterology, 15 (1) p. 38. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2416C6CBDE27]
Spectrum of digoxin-induced ocular toxicity: a case report and literature review.
Renard D., Rubli E., Voide N., Borruat F.X., Rothuizen L.E., 2015. Bmc Research Notes, 8 (1) p. 368. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_08D50AFE3918]
 
Therapeutic Drug Monitoring of Antiepileptic Drugs in the 21st Century
André P., Novy J., Decosterd LA, Buclin T., Rothuizen LE, 2015/01/01. Epileptologie 32 pp. 78-84.
[serval:BIB_563351C391E5]
2014
 
Atteintes tendineuses multiples sous traitement de statines : rapport de cas et revue de la litterature
Renard Delphine, Livio Françoise, 2014/10. Forum Medical Suisse, 14 (43) pp. 805-807.
[URN][serval:BIB_D366EE39E466]
 
Nouveaux traitements de l'hépatite C: aspects pharmacologiques et potentiel d'interaction [New hepatitis C treatments: pharmacological considerations and potential for drug interactions].
Chtioui H., Buclin T., Moradpour D., 2014/09. Revue Médicale Suisse, 10 (440) pp. 1600-4, 1606.
[URN][Pmid][serval:BIB_137CFB3E0910]
Long-term effects of cannabis on brain structure.
Battistella G., Fornari E., Annoni J.M., Chtioui H., Dao K., Fabritius M., Favrat B., Mall J.F., Maeder P., Giroud C., 2014/08. Neuropsychopharmacology, 39 (9) pp. 2041-2048. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14EC6BEB80DF]
 
Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
Mosha D., Guidi M., Mwingira F., Abdulla S., Mercier T., Decosterd L.A., Csajka C., Genton B., 2014/08. Antimicrobial Agents and Chemotherapy, 58 (8) pp. 4583-4592. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2037BBD1EF7C]
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_72BDC14B7721]
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L., Baerlocher G.M., Duchosal M.A. et al., 2014. Cancer Chemotherapy and Pharmacology, 74 (6) pp. 1307-1319. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8EFC5835C440]
 
CRTC3 Polymorphisms are not associated with obesity in swiss psychiatric populations
Quteineh L, Vandenberghe F, Rezaee MG, Choong E, Morgui NS, Delacretaz A, Preisig M, Von Gunten A, Conus P, Eap C., 2014. dans European Psychiatry. Peer-reviewed.
[DOI][serval:BIB_21280335216B]
Enzyme and acid deconjugation of plasma sulfated metanephrines.
Glauser M., Metrailler M., Gerber-Lemaire S., Centeno C., Seghezzi C., Dunand M., Abid K., Herren A., Grouzmann E., 2014. Clinica Chimica Acta; International Journal of Clinical Chemistry, 430 pp. 125-128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B6C7D6A06DEF]
 
EzeCHiel: a story of individualized medicine validation - case of gentamicin dosing regimen optimisation in newborns
Fuchs A., Thoma Y., Sutter Y., Stadelmann J., Csajka C., Guidi M., Buclin T., Widmer N., 2014. dans Nano-Tera Annual Plenary Meeting 2014: Virtual Edition.
[serval:BIB_0B32327B859F]
 
Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virus
Lakatos B., Stoeckle M., Elzi L., Battegay M., Marzolini C., 2014. Swiss Med Wkly, 144 pp. w13906. Peer-reviewed.
[DOI][Pmid][serval:BIB_42F980B2A895]
 
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
Mercier T., Tissot F., Gardiol C., Corti N., Wehrli S., Guidi M., Csajka C., Buclin T., Couet W., Marchetti O. et al., 2014. Journal of Chromatography. A, 1369 pp. 52-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0D0099C7E204]
Is HLA-A*3101 screening cost-effective for preventing carbamazepine-induced severe toxidermia?
Decollogny Anne, Pinget Christophe, Rossetti Andrea, Buclin Thierry, Livio Françoise, 2014. dans European and Swiss Congress of Internal Medicine.
[URN][serval:BIB_62DC0CDAF100]
 
Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.
Gotta V., Bouchet S., Widmer N., Schuld P., Decosterd L.A., Buclin T., Mahon F.X., Csajka C., Molimard M., 2014. Leukemia Research, 38 (7) pp. 764-772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F6749D7DFF3]
 
Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique [Pharmacokinetic Alterations in Pregnancy and Use of Therapeutic Drug Monitoring].
Panchaud A., Weisskopf E., Winterfeld U., Baud D., Guidi M., Eap C.B., Csajka C., Widmer N., 2014. Therapie, 69 (3) pp. 223-234. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_18592A49D874]
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
Hasse B., Iff M., Ledergerber B., Calmy A., Schmid P., Hauser C., Cavassini M., Bernasconi E., Marzolini C., Tarr P.E. et al., 2014. Open Forum Infectious Diseases, 1 (2) pp. ofu040.
[URN][DOI][Pmid][serval:BIB_44F79E67FED2]
 
Perampanel: a significant liver enzyme inducer in some patients?
Novy J., Rothuizen L.E., Buclin T., Rossetti A.O., 2014. European Neurology, 72 (3-4) pp. 213-216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_73F938A4F28D]
 
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Stancu I., Alnawaqil A.M., Bula C. et al., 2014. British Journal of Clinical Pharmacology, 78 (1) pp. 135-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D0309E8CA034]
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
Arab-Alameddine M., Lubomirov R., Fayet-Mello A., Aouri M., Rotger M., Buclin T., Widmer N., Gatri M., Ledergerber B., Rentsch K. et al., 2014. Journal of Antimicrobial Chemotherapy, 69 (9) pp. 2489-2498. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1E8FAB4C9089]
 
Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Fuchs A., Guidi M., Giannoni E., Werner D., Buclin T., Widmer N., Csajka C., 2014. British Journal of Clinical Pharmacology, 78 (5) pp. 1090-1101. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_44A869ECA1E5]
 
Predictive values of apetite and early weight increase for long-term weight variation during psychotropic treatment
Vandenberghe F, Rezaee MG, Choong E, Morgui NS, Delacretaz A, Preisig M, Von Gunten A, Conus P, Eap C., 2014. dans European Psychiatry. Peer-reviewed.
[DOI][WoS][serval:BIB_2A8C03791C10]
 
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Weber-Schoendorfer C., Chambers C., Wacker E., Beghin D., Bernard N., Network of French Pharmacovigilance Centers, Shechtman S., Shechtman S., Johnson D., Cuppers-Maarschalkerweerd B. et al., 2014. Arthritis and Rheumatology, 66 (5) pp. 1101-1110.
[DOI][WoS][Pmid][serval:BIB_A049FDC67BE8]
 
Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey.
Csajka C., Jaquet A., Winterfeld U., Meyer Y., Einarson A., Panchaud A., 2014. Swiss Medical Weekly, 144 pp. w13936.
[URN][DOI][WoS][Pmid][serval:BIB_AF074CA6B747]
2013
 
THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?
Fabritius M., Favrat B., Chtioui H., Battistella G., Annoni J.M., Appenzeller M., Dao K., Fornari E., Lauer E., Mall J.F. et al., 2013/10/31. Drug testing and analysis, 6 (1-2) pp. 155-163. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_476BC61913C2]
 
CYP2W1: Endogenous function and role in cancer therapy
Choong E., Guo J., Persson A., Virding S., Mkrtchian S., Ingelman-Sundberg M., 2013/09/28. dans Second ESPT Conference “Pharmacogenomics: From Cell to Clinic.
[serval:BIB_7C4D4B146A3D]
 
Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach
Siccardi M., Marzolini C., Seden K., Almond L., Kirov A., Khoo S., Owen A., Back D., 2013/07. Clin Pharmacokinet, 52 (7) pp. 583-92. Peer-reviewed.
[DOI][Pmid][serval:BIB_FD8C145BB564]
 
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Alnawaqil A.M., Maurer S., Zumbach S. et al., 2013/03. Clinical pharmacokinetics, 52 (3) pp. 211-223. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6598521C6000]
 
Abus de psychotropes : médicaments et drogues
Yersin Bertrand, Feiner Adam-Scott, Livio Françoise, 2013. pp. 246-256 dans Médecine d'urgence préhospitalière chap. 30, Editions Médecine & Hygiène .
[serval:BIB_D22CDF9953EE]
 
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (11) p. 1440.
[DOI][WoS][Pmid][serval:BIB_ECF16CE99D2A]
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M., Chtioui H., Battistella G., Annoni J.M., Dao K., Favrat B., Fornari E., Lauer E., Maeder P., Giroud C., 2013. Analytical and Bioanalytical Chemistry, 405 (30) pp. 9791-9803.
[URN][DOI][WoS][Pmid][serval:BIB_F01DAEEAD312]
 
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
Dobrinas M., Crettol S., Oneda B., Lahyani R., Rotger M., Choong E., Lubomirov R., Csajka C., Eap C.B., 2013. Pharmacogenetics and Genomics, 23 (2) pp. 84-93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0FCBF667C36]
 
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Staehli Hodel E.M., Csajka C., Ariey F., Guidi M., Kabanywanyi A.M., Duong S., Decosterd L.A., Olliaro P., Beck H.P., Genton B., 2013. Antimicrobial Agents and Chemotherapy, 57 (2) pp. 950-958.
[DOI][WoS][Pmid][serval:BIB_0195967C8F4F]
 
High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate.
Dunand M., Gubian D., Stauffer M., Abid K., Grouzmann E., 2013. Analytical Chemistry, 85 (7) pp. 3539-3544.
[DOI][WoS][Pmid][serval:BIB_DC2104614369]
 
Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data.
Dao K., Védy D., Lopez J., Staneczek O., Buclin T., Livio F., 2013. International journal of hematology, 97 (2) pp. 299-300.
[DOI][WoS][Pmid][serval:BIB_97E8D3711140]
Influence of CRTC1 Polymorphisms on Body Mass Index and Fat Mass in Psychiatric Patients and the General Adult Population.
Choong E., Quteineh L., Cardinaux J.R., Gholam-Rezaee M., Vandenberghe F., Dobrinas M., Bondolfi G., Etter M., Holzer L., Magistretti P. et al., 2013. JAMA Psychiatry, 70 (10) pp. 1011-1019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1BC1C0DFA15B]
 
Lack of Enantioselectivity in the SULT1A3-catalyzed Sulfoconjugation of Normetanephrine Enantiomers: An In Vitro and Computational Study.
Grouzmann E., Gualtierotti J.B., Gerber-Lemaire S., Abid K., Brakch N., Pedretti A., Testa B., Vistoli G., 2013. Chirality, 25 pp. 28-34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA02AD236F60]
 
Médicaments, grossesse et allaitement.
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2013. BabyGuide - le manuel officiel suisse pp. 31-33.
[serval:BIB_E3F0E72736C3]
Pharmacogenetic Study on Risperidone Long-Acting Injection: Influence of Cytochrome P450 2D6 and Pregnane X Receptor on Risperidone Exposure and Drug-Induced Side-Effects.
Choong E., Polari A., Kamdem R.H., Gervasoni N., Spisla C., Sirot E.J., Bickel G.G., Bondolfi G., Conus P., Eap C.B., 2013. Journal of Clinical Psychopharmacology, 33 (3) pp. 289-298. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_86C0833D4954]
 
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Lubomirov R., Arab-Alameddine M., Rotger M., Fayet-Mello A., Martinez R., Guidi M., di Iulio J., Cavassini M., Günthard H.F., Furrer H. et al., 2013. Pharmacogenetics and Genomics, 23 (1) pp. 9-18. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CDA03D8C1D2B]
 
Pharmacokinetic interaction between methotrexate and chloral hydrate.
Dao K., Ivanyuk A., Buclin T., Beck-Popovic M., Diezi M., 2013. Pediatric Blood and Cancer, 60 (3) pp. 518-520.
[URN][DOI][WoS][Pmid][serval:BIB_2011B1C22106]
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel E.M., Guidi M., Zanolari B., Mercier T., Duong S., Kabanywanyi A.M., Ariey F., Buclin T., Beck H.P., Decosterd L.A. et al., 2013. Malaria Journal, 12 p. 235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35BEA32B625E]
 
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.
Haouala A., Widmer N., Guidi M., Montemurro M., Leyvraz S., Buclin T., Eap C.B., Decosterd L.A., Csajka C., 2013. British Journal of Clinical Pharmacology, 75 (4) pp. 1007-1018. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CF51D91AAB14]
Pregnancy outcome following maternal exposure to Mirtazapine: Preliminary results of a collaborative ENTIS study.
Winterfeld U., Buclin T., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., te Winkel B., Clementi M., Pistelli A. et al., 2013. pp. e1-e2 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
[URN][serval:BIB_26030447190E]
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76900E4385FF]
 
Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations.
Noetzli M., Guidi M., Ebbing K., Eyer S., Zumbach S., Giannakopoulos P., von Gunten A., Csajka C., Eap C.B., 2013. Therapeutic Drug Monitoring, 35 (2) pp. 270-275. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A5DFF6BBD3DF]
 
Second ESPT Conference “Pharmacogenomics: From Cell to Clinic”
ESPT Conference (eds.), 2013/01/01., 28 3.
[DOI][serval:BIB_C831D67D85A3]
 
The brain entry of HIV-1 protease inhibitors is facilitated when used in combination
Marzolini C., Mueller R., Li-Blatter X., Battegay M., Seelig A., 2013. Mol Pharm, 10 (6) pp. 2340-9. Peer-reviewed.
[DOI][Pmid][serval:BIB_0C13E1E15CAD]
Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving.
Battistella G., Fornari E., Thomas A., Mall J.F., Chtioui H., Appenzeller M., Annoni J.M., Favrat B., Maeder P., Giroud C., 2013/01. Plos One, 8 (1) pp. e52545. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EF6F5D1419B9]
2012
 
Hypertension intracrânienne idiopathique: quand y penser?
Goulouti Eleni, Renard Delphine, Kurzbuch Arthur, Wiesel Paul, Merz Laurent, 2012/03/14. Forum Médical Suisse ‒ Swiss Medical Forum, 12 (11).
[DOI][serval:BIB_4F4757CCA9CA]
 
An agenda for UK clinical pharmacology: Monitoring drug therapy
Buclin T., Gotta V., Fuchs A., Widmer N., Aronson J., 2012. British Journal of Clinical Pharmacology, 73 (6) pp. 917-923.
[DOI][Pmid][serval:BIB_A60313C95E34]
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
Glass T.R., Rotger M., Telenti A., Decosterd L., Csajka C., Bucher H.C., Günthard H.F., Rickenbach M., Nicca D., Hirschel B. et al., 2012/01. Plos One, 7 (1) pp. e29186. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5217BD6F9449]
 
Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Guidi M., Arab-Alameddine M., Rotger M., Aouri M., Telenti A., Decosterd L.A., Buclin T., Csajka C., Swiss HIV Cohort Study, 2012. Chimia, 66 (5) pp. 291-295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4CE4C9D2166]
 
Efavirenz in an obese HIV-infected patient – a report and an in vitro–in vivo extrapolation model indicate risk of underdosing
de Roche Mirjam, Siccardi Marco, Stoeckle Marcel, Livio Françoise, Back David, Battegay Manuel, Marzolini Catia, 2012. Antiviral therapy, 17 (7) pp. 1381-1384. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B532405FD6A]
 
Management of deficient lactation in Switzerland and Canada: a survey of midwives' current practices.
Winterfeld U., Meyer Y., Panchaud A., Einarson A., 2012. Breastfeeding Medicine, 7 pp. 317-318.
[DOI][WoS][Pmid][serval:BIB_204FB7BDDD19]
 
Maternal antiretroviral prophylaxis and breastfeeding
Marzolini C., Gray G. E., 2012. Antivir Ther, 17 (8) pp. 1503-6. Peer-reviewed.
[DOI][Pmid][serval:BIB_CF7BF57F3E84]
 
Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.
Grouzmann E., Matter M., Bilz S., Herren A., Triponez F., Henzen C., Kim K.S., Zulewski H., Buclin T., Brakch N. et al., 2012. Journal of Clinical Endocrinology and Metabolism, 97 (8) pp. 2773-2781.
[DOI][WoS][Pmid][serval:BIB_15AEE025DDEF]
 
Pharmacie clinique en Suisse romande
Guignard B, Csajka Chantal, Beney J, Bugnon Olivier, Bonnabry Pascal, 2012. pp. 1277-1290 dans Calop J, Limat S, Fernandez C, Aulagner G (eds.) Pharmacie clinique et thérapeutique chap. 65, Elsevier Masson.
[serval:BIB_5F0A644D8CEE]
 
Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model.
Siccardi M., Almond L., Schipani A., Csajka C., Marzolini C., Wyen C., Brockmeyer N.H., Boffito M., Owen A., Back D., 2012. Clinical Pharmacology and Therapeutics, 92 (4) pp. 494-502.
[DOI][WoS][Pmid][serval:BIB_974D19D0A162]
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2D63B38436E]
 
Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population.
Choong E., Bondolfi G., Etter M., Jermann F., Aubry J.M., Bartolomei J., Gholam-Rezaee M., Eap C.B., 2012. Journal of Psychiatric Research, 46 (4) pp. 540-548. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B4C1EAC258AB]
Synthetic calibrators for the analysis of total metanephrines in urine: revisiting the conditions of hydrolysis.
Simonin J., Gerber-Lemaire S., Centeno C., Seghezzi C., Iglesias K., Abid K., Grouzmann E., 2012. Clinica Chimica Acta, 413 (11-12) pp. 998-1003. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4DA47379F47]
Utilisation des laxatifs à l'Hôpital
Dao Kim, Renard Delphine, Livio Françoise, Buclin Thierry, De Giorgi I, 2012. GSASA Journal 26 pp. 27-31.
[URN][serval:BIB_AEFD6225CB20]
2011
 
Syndrome métabolique et antipsychotiques atypiques: recommandations et prise en charge clinique
Solida Alexandra, Choong Eva, Eap Chin, 2011/11/01. L’Information psychiatrique, 87 (9) pp. 715-24.
[serval:BIB_38CA59D000DE]
 
14ème Journée de Recherche des Départements de Psychiatrie de Genève et de Lausanne
Choong E, Conus P, Eap C, Bondolfi G, Von Gunten A, Preisig M, 2011/06/01. dans Clinical and pharmacogenetic studies on response and side-effects under psychotropic drugs.
[serval:BIB_F75FCBF7ED3D]
 
[Drug-drug interactions with HIV treatments]
Mossdorf E., Marzolini C., Fasel D., Mello Fayet A., Blum C., Donath M., Battegay M., 2011. Praxis (Bern 1994), 100 (19) pp. 1193-6. Peer-reviewed.
[DOI][Pmid][serval:BIB_46F353253623]
Additifs alimentaires et troubles de l’attention/hyperactivité chez l’enfant
Diezi Manuel, Buclin Thierry, Diezi Jacques, 2011. Paediatrica, 22 (5) pp. 12-15.
[URN][serval:BIB_B38222B6B682]
Ageing with HIV: medication use and risk for potential drug-drug interactions.
Marzolini C., Back D., Weber R., Furrer H., Cavassini M., Calmy A., Vernazza P., Bernasconi E., Khoo S., Battegay M. et al., 2011. Journal of Antimicrobial Chemotherapy, 66 (9) pp. 2107-2111.
[URN][DOI][WoS][Pmid][serval:BIB_91EDE0960CA0]
 
Cholelithiasis: obesity complication or orlistat adverse reaction?
Melnikova Martinez-Esteve A., Genin B., Livio F., Produit S., Cheseaux J.J., Llor J., Marcoz J., Tabin R., 2011., Congrès commun des Sociétés suisses de Pédiatrie, Chirurgie pédiatrique, Psychiatrie et Psychothérapie d'enfants et d'adolescents, Montreux pp. 31S dans Swiss Medical Weekly.
[serval:BIB_887DB7B7B509]
 
Dosages plasmatiques de médicaments psychotropes à des fins thérapeutiques et tests pharmacogénétiques
Baumann Pierre, 2011. pp. 71-75 dans Calanca Aldo, Bryois Christian, Buclin Thierry (eds.) Vade-mecum de thérapqutique psychiatrique, Editions Médecine & Hygiène.
[serval:BIB_2DE9C4E31C1D]
 
Evaluation of risk perception related to drug use during pregnancy: a Swiss survey
Jaquet A., Winterfeld U., Meyer Y., Buclin T., Csajka C., Panchaud A., 2011. pp. 422-423 dans 39th ESCP European Symposium on Clinical Pharmacy and 13th SFPC Congress: Clinical Pharmacy at the Front Line of Innovations, International Journal of Clinical Pharmacy. Peer-reviewed.
[WoS][serval:BIB_9D071EE1F834]
 
Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood stabilizers.
Choong E, Bondolfi G, Eap C, Oneda B, Etter M, 2011/01/01. dans 31st Annual meeting of Swiss Society of Biological Psychiatry, January 2011, Lausanne, Switzerland..
[serval:BIB_3E507D03509E]
 
Pregnancy outcome following maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 32 dans 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, British Journal of Clinical Pharmacology. Peer-reviewed.
[WoS][serval:BIB_356C95ABEEAB]
 
Pregnancy Outcome Following Maternal Exposure To Statins: A Multicenter Prospective Study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 142 dans 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Basic & Clinical Pharmacology & Toxicology. Peer-reviewed.
[WoS][serval:BIB_097345A56E49]
 
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.
Choong E., Rudaz S., Kottelat A., Haldemann S., Guillarme D., Veuthey J.L., Eap C.B., 2011. Journal of Chromatography. B, 879 (19) pp. 1544-1550. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BEFDB40A967]
 
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Dobrinas M., Choong E., Noetzli M., Cornuz J., Ansermot N., Eap C.B., 2011. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 879 (30) pp. 3574-3582. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_36445F679F00]
 
Simultaneous determination of antidementia drugs by HPLC-MS: validation data of the method and plasma level determinations in 300 patients
Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. p. 501 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.
[WoS][serval:BIB_76D89205506F]
 
Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring.
Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. Therapeutic Drug Monitoring, 33 (2) pp. 227-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_982CF39955B2]
 
Traitements de fer: preuves de l'efficacité et bonne pratique clinique [Iron therapy: proof of efficacy and good clinical practice].
Renard D., Favrat B., Livio F., Buclin T., 2011. Revue Médicale Suisse, 7 (292) pp. 923-927.
[Pmid][serval:BIB_CBF2C240C020]
2010
Cellular factors implicated in prion replication.
Abid K., Morales R., Soto C., 2010/06/03. FEBS letters, 584 (11) pp. 2409-2414. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7A30F6FE716E]
 
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Lubomirov R., di Iulio J., Fayet A., Colombo S., Martinez R., Marzolini C., Furrer H., Vernazza P., Calmy A., Cavassini M. et al., 2010. Pharmacogenetics and Genomics, 20 (4) pp. 217-230.
[DOI][WoS][Pmid][serval:BIB_F0BE883DE124]
Anwendung von Galaktogoga in der Schweiz
Meyer Y., Winterfeld U., Panchaud A., 2010. Hebamme.ch = Sage-femme.ch 5 pp. 4-9. Peer-reviewed.
[URN][serval:BIB_9C6BC5A01BBA]
 
Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood stabilizers
Choong Eva, Eap C, 2010. pp. s214 dans European Neuropsychopharmacology.
[DOI][WoS][serval:BIB_71536CB58E69]
 
Pharmacovigilance update [Pharmacovigilance update]
Livio F., Ivanyuk A., Biollaz J., Rothuizen L., Buclin T., 2010. Revue Médicale Suisse, 6 (232) pp. 128-131.
[Pmid][serval:BIB_6D790D62BAB3]
 
Pregnancy outcome after maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A., Berlin M. et al., 2010. dans 21st Annual Meeting of the European Network Teratogen Information Services (ENTIS).
[serval:BIB_A6F9F6CDE49A]
 
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C., Elzi L., Gibbons S., Weber R., Fux C., Furrer H., Chave J.P., Cavassini M., Bernasconi E., Calmy A. et al., 2010. Antiviral Therapy, 15 (3) pp. 413-423.
[DOI][WoS][Pmid][serval:BIB_6BCAC526F0B2]
 
The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution.
Choong E., Dobrinas M., Carrupt P.A., Eap C.B., 2010. Expert Opinion On Drug Metabolism and Toxicology, 6 (8) pp. 953-965. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B9CC1CA46639]
 
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Elzi L., Marzolini C., Furrer H., Ledergerber B., Cavassini M., Hirschel B., Vernazza P., Bernasconi E., Weber R., Battegay M. et al., 2010. Archives of Internal Medicine, 170 (1) pp. 57-65.
[DOI][WoS][Pmid][serval:BIB_FFDD9D2AEA04]
2009
 
Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus
Mertz D., Battegay M., Marzolini C., Mayr M., 2009/07. Am J Kidney Dis, 54 (1) pp. e1-4. Peer-reviewed.
[DOI][Pmid][serval:BIB_47690AB48B71]
 
Spectroscopy of protonated peptides assisted by infrared multiple photon excitation.
Guidi M., Lorenz U.J., Papadopoulos G., Boyarkin O.V., Rizzo T.R., 2009/02/05. The journal of physical chemistry. A, 113 (5) pp. 797-799. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28F7B71C2C75]
 
Formation et recherche en pharmacie hospitalière et communautaire – état des lieux et perspectives en Suisse romande
Pannatier André, Bugnon Olivier, Csajka Chantal, Bonnabry Pascal, 2009. Pharmactuel, 42 (Suppl. 1) pp. 53-61. Peer-reviewed.
[serval:BIB_AE234F1ABC0F]
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.
Abid K., Rochat B., Lassahn P.G., Stöcklin R., Michalet S., Brakch N., Aubert J.F., Vatansever B., Tella P., De Meester I. et al., 2009. Journal of Biological Chemistry, 284 (37) pp. 24715-24724.
[URN][DOI][WoS][Pmid][serval:BIB_9B09F50AB826]
 
Méthylphénidate et abus
Livio F., Rauber-Lüthy C., Biollaz J., Holzer L., Winterfeld U., Buclin T., 2009. Paediatrica : Bulletin der Schweizerischen Gesellschaft für Pädiatrie (SGP) = Bulletin de la Société suisse de pédiatrie (SSP), 20 (5) pp. 41-44.
[serval:BIB_652ACBB6A3FD]
 
Pharmacodynamic interaction between SSR180575 and enalapril on the blood pressure response to angiotensin-I challenges in healthy normotensive male volunteers
Livio F., Buclin T., Nussberger J., Appenzeller M., Gaud C., Duluc M.E., Pinquier J.L., Biollaz J., 2009., Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Edinburgh p. 83 dans Basic and Clinical Pharmacology and Toxicology.
[serval:BIB_C2790E8478F7]
 
Pratique en cas de lactogénèse insuffisante
Meyer Yvonne, Winterfeld Ursula, Panchaud Alice, 2009. Hebamme.ch = Sage-femme.ch, 2009 (10) pp. 40-45.
[serval:BIB_1FFC319EA852]
 
Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS.
Choong E., Rudaz S., Kottelat A., Guillarme D., Veuthey J.L., Eap C.B., 2009. Journal of Pharmaceutical and Biomedical Analysis, 50 (5) pp. 1000-1008. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9702E4751B4]
2008
 
Estimation de la fonction rénale par l'equation MDRD: intérêt et limites pour l'adaptation des doses de médicaments [Renal function estimation by MDRD equation: interest and limitations for drug dosing].
Livio F., Biollaz J., Burnier M., 2008. Revue Médicale Suisse, 4 (181) pp. 2596-2600.
[Pmid][serval:BIB_4BEE75947F22]
 
Les risques liés à l'utilisation des rétinoïdes topiques pendant la grossesse
Panchaud A., Stah B., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G., Rothuizen L.E. et al., 2008. Tribune médicale = Medical Tribune, 14 (Mai 21-22) p. 11.
[serval:BIB_7CB319A8DBDE]
 
Médicaments et allaitement: quelques éléments a considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale Suisse, 4 (146) pp. 540-545.
[Pmid][serval:BIB_8016F6851F68]
 
Médicaments et allaitement: quelques éléments à considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale suisse, 4 (146) pp. 540-545.
[Pmid][serval:BIB_D2B0759CD078]
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., Buclin T., Biollaz J., 2008. Revue Médicale Suisse, 4 (140) pp. 150-154.
[Pmid][serval:BIB_1AC8DF45F435]
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., Buclin T., Biollaz J., 2008. Revue Médicale Suisse, 4 (140) pp. 150-154.
[Pmid][serval:BIB_C927A68F240C]
 
Tests pharmacogénétiques: bientôt avant chaque prescription [Pharmacogenetic testing: soon before every prescription?]
Buclin T., Colombo S., Biollaz J., 2008. Revue Médicale Suisse, 4 (165) pp. 1666-1670.
[Pmid][serval:BIB_790D0D406387]
 
Transporter-mediated protection against thiopurine-induced hematopoietic toxicity
Krishnamurthy P., Schwab M., Takenaka K., Nachagari D., Morgan J., Leslie M., Du W., Boyd K., Cheok M., Nakauchi H. et al., 2008. Cancer Res, 68 (13) pp. 4983-9. Peer-reviewed.
[DOI][Pmid][serval:BIB_B46C08CD3C0B]
2007
 
Conformation-specific infrared and ultraviolet spectroscopy of tyrosine-based protonated dipeptides.
Stearns J.A., Guidi M., Boyarkin O.V., Rizzo T.R., 2007/10/21. The Journal of chemical physics, 127 (15) p. 154322. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F6052164E85]
 
Conformation-specific spectroscopy and photodissociation of cold, protonated tyrosine and phenylalanine.
Stearns J.A., Mercier S., Seaiby C., Guidi M., Boyarkin O.V., Rizzo T.R., 2007/09/26. Journal of the American Chemical Society, 129 (38) pp. 11814-11820. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7183D52C78C2]
 
A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression
Marzolini C., Tirona R. G., Gervasini G., Poonkuzhali B., Assem M., Lee W., Leake B. F., Schuetz J. D., Schuetz E. G., Kim R. B., 2007/08. Mol Endocrinol, 21 (8) pp. 1769-80. Peer-reviewed.
[DOI][Pmid][serval:BIB_B63F6D18F6AD]
The prion strain phenomenon: molecular basis and unprecedented features.
Morales R., Abid K., Soto C., 2007/06. Biochimica et biophysica acta, 1772 (6) pp. 681-691. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A27B347E24C0]
 
Some properties of lysozyme--lithium perfluorononanoate complexes.
Ciurleo A., Cinelli S., Guidi M., Bonincontro A., Onori G., Mesa C.L., 2007/02. Biomacromolecules, 8 (2) pp. 399-405. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_682343D08A56]
 
Effect of dronedarone on renal function in healthy subjects.
Tschuppert Y., Buclin T., Rothuizen L.E., Decosterd L.A., Galleyrand J., Gaud C., Biollaz J., 2007. British Journal of Clinical Pharmacology, 64 (6) pp. 785-791. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29365D442E7A]
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
Liu R., Abid K., Pichardo J., Pazienza V., Ingravallo P., Kong R., Agrawal S., Bogen S., Saksena A., Cheng K.C. et al., 2007/01. The Journal of antimicrobial chemotherapy, 59 (1) pp. 51-58. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9CAE2093881C]
2006
The intriguing prion disorders
Abid K., Soto C., 2006/10. Cellular and Molecular Life Sciences, 63 (19-20) pp. 2342-2351.
[URN][DOI][WoS][Pmid][serval:BIB_7AB8D6FA8E01]
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L. et al., 2006/05/09. Proceedings of the National Academy of Sciences of the United States of America, 103 (19) pp. 7408-7413. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D90919F8880C]
 
Generiques et article 38a OPAS: quel impact? [Generic drugs and legal incentives: which impact?]
Livio F., Buclin T., Pannatier A., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 966-9.
[Pmid][serval:BIB_6747553D6285]
 
Ne pas negliger le risque de surtraitement: l'exemple des antiepiteptiques. [Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]
Rothuizen L. E., Buclin T., Reichhart M., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 976-80.
[Pmid][serval:BIB_CDD994234E2B]
 
Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.
Colombo S., Béguin A., Marzolini C., Telenti A., Biollaz J., Decosterd L.A., 2006/02. Journal of Chromatography. B, 832 (1) pp. 138-143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_240D221E7E2F]
 
Attitude de prescription chez la femme enceinte : exemple de prise en charge d'un état dépressif
Panchaud A., Rothuizen L.E., Buclin T., 2006. Swiss Medical Forum = Forum Médical Suisse, 6 (43) pp. 961-964. Peer-reviewed.
[serval:BIB_F9F8EB1B65FD]
 
Effets du cannabis oral et du dronabinol sur la capacité à conduire [Effects of oral cannabis and dronabinol on driving capacity]
Giroud C., Augsburger M., Favrat B., Menetrey A., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mathieu S., Castella V. et al., 2006. Annales Pharmaceutiques Françaises, 64 (3) pp. 161-172.
[Pmid][serval:BIB_85D07622711E]
 
Exposition intra-utérine aux SSRI et syndrome de sevrage néonatal : un recensement des mères traitées et un suivi du développement psychomoteur de l'enfant sont-ils nécessaires?
Jequier M., Rothuizen L.E., Buclin T., Hohlfeld P., Tolsa J.F., Tabin R., 2006. Paediatrica : Bulletin der Schweizerischen Gesellschaft für Pädiatrie (SGP) = Bulletin de la Société suisse de pédiatrie (SSP), 17 (4) pp. 34-37.
[serval:BIB_1DAD27703468]
 
Malformations cardiaques congénitales sous paroxétine
Panchaud A., Rothuizen L.E., Buclin T., 2006. Journal Suisse de Pharmacie, 144 (8) pp. 292-295.
[serval:BIB_F6F973A994E2]
 
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study
Ribaudo H. J., Haas D. W., Tierney C., Kim R. B., Wilkinson G. R., Gulick R. M., Clifford D. B., Marzolini C., Fletcher C. V., Tashima K. T. et al., 2006. Clin Infect Dis, 42 (3) pp. 401-7. Peer-reviewed.
[DOI][Pmid][serval:BIB_F8F912D966CB]
 
Pharmacovigitance--pharmaco-epidemiologie. [Trends in drug therapy]
Livio F., Buclin T., Biollaz J., 2006/01. Revue Médicale Suisse, 2 (48) pp. 155-9.
[Pmid][serval:BIB_A06661C6BF04]
Protein misfolding cyclic amplification for diagnosis and prion propagation studies.
Castilla J., Saá P., Morales R., Abid K., Maundrell K., Soto C., 2006. Methods in enzymology, 412 pp. 3-21. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4ECC21052C6B]
 
Troubles anxieux provoqués par le cannabis: sont-ils explicables par des différences de métablisme ou par une vulnérabilité génétique différenciée aux effets psychotropes des cannabinoïdes
Giroud C., Castella V., Favrat B., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Augsburger M., 2006. Annales de Toxicologie Analytique, XVIII (3) pp. 185-186. Peer-reviewed.
[serval:BIB_11D814EDF229]
2005
 
Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine.
Rossetti G., Livio F., Roulet E., Hofer M.F., 2005/08. Pediatric allergy and immunology, 16 (5) pp. 453-455. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8208F10CD4E7]
 
Placental transfer of antiretroviral drugs
Marzolini C., Kim R. B., 2005/08. Clin Pharmacol Ther, 78 (2) pp. 118-22. Peer-reviewed.
[DOI][Pmid][serval:BIB_1F1B7FFB4CA3]
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
Abid K., Pazienza V., de Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., Rossi C., Mangia A., Negro F., 2005/05. Journal of hepatology, 42 (5) pp. 744-751. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_60A0F70D097A]
Two cases of "cannabis acute psychosis" following the administration of oral cannabis.
Favrat B., Ménétrey A., Augsburger M., Rothuizen L.E., Appenzeller M., Buclin T., Pin M., Mangin P., Giroud C., 2005/04/01. BMC psychiatry, 5 p. 17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50A330F58CDE]
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A., Augsburger M., Favrat B., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Giroud C., 2005. Journal of Analytical Toxicology, 29 (5) pp. 327-338. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A94B2E9DBD5F]
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.
Fellay J., Marzolini C., Decosterd L., Golay K.P., Baumann P., Buclin T., Telenti A., Eap C.B., 2005. European journal of clinical pharmacology, 60 (12) pp. 865-73. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E60EAA242E4]
2004
 
Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
Colombo S., Guignard N., Marzolini C., Telenti A., Biollaz J., Decosterd L. A., 2004/10. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 810 (1) pp. 25-34.
[DOI][WoS][Pmid][serval:BIB_21D53DE5F776]
 
Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus
Csajka C., Marzolini C., Fattinger K., Decosterd L. A., Telenti A., Biollaz J., Buclin T., 2004/09. Antimicrobial Agents and Chemotherapy, 48 (9) pp. 3226-32.
[DOI][WoS][Pmid][serval:BIB_1C445DFD3180]
 
Douleurs abdominales et ictere cholestatique recidivant. [Abdominal pain and recurrent cholestatic jaundice]
Livio Ndiaye F., Wiesel P. H., Goy J. J., Genton A., 2004/06. Schweizerische Rundschau fur Medizin Praxis, 93 (24) pp. 1051-4.
[Pmid][serval:BIB_23B1384DA399]
 
Pharmacogenomics of the OATP and OAT families
Marzolini C., Tirona R. G., Kim R. B., 2004/04. Pharmacogenomics, 5 (3) pp. 273-82. Peer-reviewed.
[DOI][Pmid][serval:BIB_56B4D87BEB7A]
MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment
Bleiber G., May M., Suarez C., Martinez R., Marzolini C., Egger M., Telenti A., 2004/02. Journal of Infectious Diseases, 189 (4) pp. 583-6.
[URN][DOI][WoS][Pmid][serval:BIB_4344DC6AC930]
 
Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use
Wasserfallen J. B., Livio F., Zanetti G., 2004. Pharmacoeconomics, 22 (13) pp. 829-37. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_900068DB354E]
 
Immunohistochemical detection of hepatitis delta antigen.
Abid K., Negro F., 2004. Methods in molecular medicine, 95 pp. 107-111. Peer-reviewed.
[DOI][Pmid][serval:BIB_AF1F3FBA21A6]
 
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study
Haas D. W., Ribaudo H. J., Kim R. B., Tierney C., Wilkinson G. R., Gulick R. M., Clifford D. B., Hulgan T., Marzolini C., Acosta E. P., 2004. AIDS, 18 (18) pp. 2391-400. Peer-reviewed.
[Pmid][serval:BIB_FBA7F629F387]
 
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini Catia, Paus Erik, Buclin Thierry, Kim Richard B., 2004. Clinical Pharmacology and Therapeutics, 75 (1) pp. 13-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_111D08D8358F]
2003
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes.
Barbey F., Bonny O., Rothuizen L., Gomez F., Burnier M., 2003. Nephrology, Dialysis, Transplantation, 18 (10) pp. 2193-2196.
[URN][DOI][WoS][Pmid][serval:BIB_FDB08EEB13B0]
 
Evaluation of online telemonitoring of drug adherence: a pilot randomized, controlled study in patients with epilepsy.
Schneider M.P, Despland P.A, Buclin Th., Burnier M, 2003. The Journal on Information Technology in Healthcare, 1(6) pp. 419-435.
[serval:BIB_29991]
 
Hyponatrémie: une histoire en deux temps... [Hyponatremia: an unusual case report]
Berwert L., Kaeser P., Livio F., Vollenweider P., Waeber G., 2003. Praxis, 92 (41) pp. 1727-32.
[Pmid][serval:BIB_A34DAD6E86F9]
 
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection.
Csajka C., Marzolini C., Fattinger K., Décosterd L.A., Fellay J., Telenti A., Biollaz J., Buclin T., 2003. Clinical pharmacology and therapeutics, 73 (1) pp. 20-30. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39A9FD8E09B3]
 
Transplantation et goutte .
Livio Ndiaye F, Dudler J, 2003. Médecine et Hygiène pp. 2099-2104.
[serval:BIB_27120]
2002
Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
Rubbia-Brandt L., Taylor S., Gindre P., Quadri R., Abid K., Spahr L., Negro F., 2002/08. The Journal of pathology, 197 (5) pp. 617-623. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0266FC684B4C]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University